Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
OneMedNet Corp (NASDAQ:ONMD) announced Wednesday that it has regained compliance with the Nasdaq Stock Market’s minimum bid price requirement. The company received written notice from Nasdaq staff on Tuesday confirming that its common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days, from September 24 through October 7.
The notification follows an earlier letter received on April 10, when Nasdaq informed OneMedNet that it was not in compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Listing Rule 5550(a)(2). The company was given until October 7 to regain compliance.
According to the latest notice, the matter is now closed and OneMedNet’s listing on the exchange is no longer at risk for this issue.
This information is based on a statement provided in the company’s recent SEC filing.
In other recent news, OneMedNet Corporation has announced several significant developments. The company has entered a multi-year partnership with Palantir Technologies to enhance its healthcare data analytics capabilities. This collaboration will integrate Palantir’s Artificial Intelligence Platform with OneMedNet’s provider network, which accesses over 5 billion administrative claims and 131 million clinical exams across more than 1,750 provider sites. Additionally, OneMedNet has partnered with Medcase to venture into the healthcare data annotation market, creating a new revenue channel in the healthcare AI ecosystem. This sector is valued at $1.5 billion in 2025 and is projected to reach $2.8 billion by 2030. Furthermore, OneMedNet has secured a partnership with one of the world’s top five medical device companies, resulting in four purchase orders under an existing master services agreement. These orders focus on delivering multimodal data to support medical imaging AI model development. These recent developments highlight OneMedNet’s strategic moves to expand and strengthen its position in the healthcare AI and data analytics markets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.